南方医科大学学报
南方醫科大學學報
남방의과대학학보
JOURNAL OF SOUTHERN MEDICAL UNIVERSITY
2015年
6期
916-921
,共6页
李明华%彭丽%杨富恒%刘思佳%王胜奇
李明華%彭麗%楊富恆%劉思佳%王勝奇
리명화%팽려%양부항%류사가%왕성기
紫杉醇%京大戟%P-糖蛋白%Ussing Chamber%透过%生物利用度
紫杉醇%京大戟%P-糖蛋白%Ussing Chamber%透過%生物利用度
자삼순%경대극%P-당단백%Ussing Chamber%투과%생물이용도
paclitaxel%Radix euphorbiae pekinensis%P-glycoprotein%Ussing chamber%permeability%oral bioavailability
目的:评价合用京大戟提取物对紫杉醇经大鼠不同肠段透过性和口服生物利用度的影响。方法分别采用体外Ussing Chamber实验和大鼠in vivo实验,选用P-糖蛋白(P-gp)抑制剂维拉帕米为阳性对照,对比京大戟提取物对紫杉醇经不同肠段透过的差异性和口服生物利用度评价。紫杉醇的体外透过液和血药浓度分别用HPLC方法和LC-MS/MS方法进行测定。结果Ussing Chamber实验中,京大戟组紫杉醇经空肠、回肠粘膜透过时,吸收方向转运(M-S)和分泌方向转运(S-M)与阳性对照组和空白组比较,表观渗透系数(Papp)均有显著性差异(P<0.05),但在结肠S-M组与空白组相比没有显著性差异(P>0.05)。表明京大戟提取物能提高紫杉醇经肠粘膜的透过性,其作用主要发生在空肠、回肠段。大鼠in vivo实验结果显示,合用京大戟提取物后,紫杉醇的药时曲线下面积(AUC)和最高血浆浓度(Cmax)的平均值显著大于空白组,明显大于阳性对照组。京大戟组紫杉醇的绝对生物利用度(AB%)为7.63%,是空白对照组的2.7倍,阳性对照组的1.8倍。结论合用京大戟提取物,能显著提高紫杉醇经肠道的吸收,在一定程度上能促进紫杉醇的口服生物利用度。
目的:評價閤用京大戟提取物對紫杉醇經大鼠不同腸段透過性和口服生物利用度的影響。方法分彆採用體外Ussing Chamber實驗和大鼠in vivo實驗,選用P-糖蛋白(P-gp)抑製劑維拉帕米為暘性對照,對比京大戟提取物對紫杉醇經不同腸段透過的差異性和口服生物利用度評價。紫杉醇的體外透過液和血藥濃度分彆用HPLC方法和LC-MS/MS方法進行測定。結果Ussing Chamber實驗中,京大戟組紫杉醇經空腸、迴腸粘膜透過時,吸收方嚮轉運(M-S)和分泌方嚮轉運(S-M)與暘性對照組和空白組比較,錶觀滲透繫數(Papp)均有顯著性差異(P<0.05),但在結腸S-M組與空白組相比沒有顯著性差異(P>0.05)。錶明京大戟提取物能提高紫杉醇經腸粘膜的透過性,其作用主要髮生在空腸、迴腸段。大鼠in vivo實驗結果顯示,閤用京大戟提取物後,紫杉醇的藥時麯線下麵積(AUC)和最高血漿濃度(Cmax)的平均值顯著大于空白組,明顯大于暘性對照組。京大戟組紫杉醇的絕對生物利用度(AB%)為7.63%,是空白對照組的2.7倍,暘性對照組的1.8倍。結論閤用京大戟提取物,能顯著提高紫杉醇經腸道的吸收,在一定程度上能促進紫杉醇的口服生物利用度。
목적:평개합용경대극제취물대자삼순경대서불동장단투과성화구복생물이용도적영향。방법분별채용체외Ussing Chamber실험화대서in vivo실험,선용P-당단백(P-gp)억제제유랍파미위양성대조,대비경대극제취물대자삼순경불동장단투과적차이성화구복생물이용도평개。자삼순적체외투과액화혈약농도분별용HPLC방법화LC-MS/MS방법진행측정。결과Ussing Chamber실험중,경대극조자삼순경공장、회장점막투과시,흡수방향전운(M-S)화분비방향전운(S-M)여양성대조조화공백조비교,표관삼투계수(Papp)균유현저성차이(P<0.05),단재결장S-M조여공백조상비몰유현저성차이(P>0.05)。표명경대극제취물능제고자삼순경장점막적투과성,기작용주요발생재공장、회장단。대서in vivo실험결과현시,합용경대극제취물후,자삼순적약시곡선하면적(AUC)화최고혈장농도(Cmax)적평균치현저대우공백조,명현대우양성대조조。경대극조자삼순적절대생물이용도(AB%)위7.63%,시공백대조조적2.7배,양성대조조적1.8배。결론합용경대극제취물,능현저제고자삼순경장도적흡수,재일정정도상능촉진자삼순적구복생물이용도。
Objective To evaluate the effect of Radix euphorbiae pekinensis extract on the permeability and bioavailability of paclitaxel co- administered orally. Methods Based on Ussing Chamber and in vivo experiment, the permeability and bioavailability of paclitaxel were evaluated after oral co-administration with radix euphorbiae pekinensis in rats. The contents of paclitaxel in the permeates and the blood samples were determined using HPLC and LC-MS/MS method, respectively. Results In Radix euphorbiae pekinensis co-administration group, the Papp of the mucosal-to-serosal (M-S) transport or serosal-to-mucosal transport (S-M) of paclitaxel in the jejunum or ileum segment differed significantly from those in verapamil co-administration group and blank control group (P<0.05), but the Papp of S-M transport in the colon showed no significant difference from that in the blank control group. In the blank group, the average absolute bioavailability (AB%) of orally administered paclitaxel was only 2.81%, compared to that of 7.63%in radix euphorbiae pekinensis group. The average AB%in verapamil group was about 1.5 times that of the blank group. Conclusion Co-administration of Radix euphorbiae pekinensis extract can increase the bioavailability of orally administered paclitaxel.